Kairos Pharma Ltd (AMEX:KAPA) price on Thursday, July 03, fall -6.33% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.65.
A look at the stock’s price movement, the close in the last trading session was $0.69, moving within a range at $0.651 and $0.69. Turning to its 52-week performance, $4.00 and $0.40 were the 52-week high and 52-week low respectively. Overall, KAPA moved 44.67% over the past month.
Kairos Pharma Ltd’s market cap currently stands at around $10.97 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
KAPA’s current price about 8.07% and -0.16% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.71, while 7-day volatility ratio is 9.58% and 13.25% in the 30-day chart. Further, Kairos Pharma Ltd (KAPA) has a beta value of 0.
If we refocus on Kairos Pharma Ltd (AMEX:KAPA), historical trading data shows that trading volumes averaged 0.79 over the past 10 days and 860.48K over the past 3 months. The company’s latest data on shares outstanding shows there are 15.83 million shares.
The 57.73% of Kairos Pharma Ltd’s shares are in the hands of company insiders while institutional holders own 9.36% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.19 million on 2025-06-13, giving us a short ratio of 0.12. The data shows that as of 2025-06-13 short interest in Kairos Pharma Ltd (KAPA) stood at 191.0 of shares outstanding, with shares short rising to 85193.0 registered in 2025-05-15. It is this reason that could see investor optimism for the KAPA stock continues to rise going into the next quarter.
